Literature DB >> 17187245

Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711-1721.

E Cerasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17187245     DOI： 10.1007/s00125-006-0573-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  The status of diabetes control and antidiabetic drug therapy in Japan--a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1).

Authors:  Masashi Kobayashi; Katsuya Yamazaki; Koichi Hirao; Mariko Oishi; Azuma Kanatsuka; Mikio Yamauchi; Hirofumi Takagi; Koichi Kawai
Journal:  Diabetes Res Clin Pract       Date:  2006-04-18       Impact factor: 5.602

2.  Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  David M Nathan; John B Buse; Mayer B Davidson; Robert J Heine; Rury R Holman; Robert Sherwin; Bernard Zinman
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  D M Nathan; J B Buse; M B Davidson; R J Heine; R R Holman; R Sherwin; B Zinman
Journal:  Diabetologia       Date:  2006-08       Impact factor: 10.122

4.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

Review 5.  Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?

Authors:  G Leibowitz; E Cerasi
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

6.  Limitations of diabetes pharmacotherapy: results from the Vermont Diabetes Information System study.

Authors:  Charles D MacLean; Benjamin Littenberg; Amanda G Kennedy
Journal:  BMC Fam Pract       Date:  2006-08-15       Impact factor: 2.497
  6 in total
  1 in total

Review 1.  Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues.

Authors:  Allan Vaag; Søren S Lund; Sørens Lund
Journal:  Eur J Endocrinol       Date:  2011-09-19       Impact factor: 6.664
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.